Identification and importance of brown adipose tissue in adult humans.
Aaron M Cypess, Sanaz Lehman, Gethin Williams...
https://pubmed.ncbi.nlm.nih.gov/19357406/Actively Recruiting
Led by University of Avignon · Updated on 2026-04-30
38
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating the effects of capsinoid dietary supplements on brown adipose tissue BAT activity in obese adolescents aged 11 to 18 years. BAT is a special type of fat that helps regulate energy use by producing heat, which may help reduce obesity. This study aims to see if capsinoid supplements combined with dietary management can increase BAT activity in this group. Participants will be randomly assigned to one of two groups. One group will receive capsules containing capsinoids, a compound found in sweet peppers and chillies, taken three times daily for four weeks. The control group will receive similar capsules without the active ingredient. Both groups will participate in a four-week multidimensional care program during the study. Throughout the study, researchers will measure changes in BAT activity using temperature differences in specific body regions before and after cold exposure. Other assessments include blood flow, metabolism, heart rate patterns, blood sugar and lipid profiles, hormone levels, body measurements, eating behavior, and pubertal development. Treatment adherence will be monitored continuously during the program, with evaluations at the start and end of the four weeks.
CONDITIONS
Study of the Effect of Capsinoid Supplementation on Brown Adipose Tissue in Obese Adolescents
A
Agnès VINET
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Avignon
Lead Sponsor
Institut Saint Pierre
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants receive capsinoid supplements or placebo capsules three times per day as part of a 4-week multidimensional care program.
Visits at the start and end of the 4-week program
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Aaron M Cypess, Sanaz Lehman, Gethin Williams...
https://pubmed.ncbi.nlm.nih.gov/19357406/Maria Chondronikola, Scott C Beeman, Richard L Wahl
https://pubmed.ncbi.nlm.nih.gov/29119565/Vicente Gilsanz, Sandra A Chung, Hollie Jackson...
https://pubmed.ncbi.nlm.nih.gov/21168855/K Chechi, J Nedergaard, D Richard
https://pubmed.ncbi.nlm.nih.gov/24165204/Francisco J Osuna-Prieto, Borja Martinez-Tellez, Guillermo Sanchez-Delgado...
https://pubmed.ncbi.nlm.nih.gov/30624591/Fabiane Ferreira Martins, Bruna Cadete Martins, Ananda Vitoria Silva Teixeira...
https://pubmed.ncbi.nlm.nih.gov/38402434/University of Avignon
Lead Sponsor
Institut Saint Pierre
Collaborating Sponsor